ストックスクリーナーアプリを入手
27.37
0.00%
0.00
アフターアワーズ：
27.33
-0.04
-0.15%
Pfizer Inc (PFE) 最新ニュース
Pfizer (PFE) Experiences Mixed Options Sentiment Amid Downgrade - GuruFocus
Is There 25% Downside For Pfizer Stock? - Forbes
Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study - TipRanks
Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game - Seeking Alpha
Pfizer Colorectal Cancer Trial Win Adds Weight To Oncology Turnaround Story - Yahoo Finance
Pfizer (PFE) Valuation Check After Recent Share Price Rebound And Mixed Earnings Signals - Yahoo Finance Singapore
Sleep Aids Market 2026-2035 Top Key Playres: Pfizer (US), - openPR.com
Essex Financial Services Inc. Trims Stock Holdings in Pfizer Inc. $PFE - MarketBeat
CenterBook Partners LP Has $12.65 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Advisors Capital Management LLC Purchases 260,742 Shares of Pfizer Inc. $PFE - MarketBeat
NEOS Investment Management LLC Purchases 223,163 Shares of Pfizer Inc. $PFE - MarketBeat
Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider - GlobeNewswire Inc.
Skandinaviska Enskilda Banken AB publ Trims Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer - Business Wire
Pfizer: The Rebound Looks Unsustainable (NYSE:PFE) - Seeking Alpha
Pfizer’s Braftovi Scores Again In Confirmatory Colorectal Cancer Trial - Citeline News & Insights
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell - marketscreener.com
Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell - TradingView
How Is The Market Feeling About Pfizer Inc? - Benzinga
Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer TrialPfizer (NYSE:PFE) - Benzinga
Pfizer's (PFE) Braftovi Shows Promise in Colorectal Cancer Trial - GuruFocus
Pfizer posts trial win for cancer therapy Braftovi (PFE:NYSE) - Seeking Alpha
Pfizer (PFE) Reports Positive Results from BREAKWATER Trial in m - GuruFocus
Pfizer Trial Updates Test Investor Views On Pipeline And Valuation - Yahoo Finance Singapore
Pfizer Inc. $PFE is PARK CIRCLE Co's 10th Largest Position - MarketBeat
Pfizer's Braftovi regimen improves progression-free survival in metastatic colorectal cancer - marketscreener.com
Rothschild & Co Redburn Adjusts Price Target on Pfizer to $25 From $23, Maintains Neutral Rating - marketscreener.com
M&G PLC Lowers Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Shell Asset Management Co. Has $1.03 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Ovarian Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact - Barchart.com
Vanguard Group Inc. Has $13.61 Billion Stock Position in Pfizer Inc. $PFE - MarketBeat
PNC Financial Services Group Inc. Sells 223,165 Shares of Pfizer Inc. $PFE - MarketBeat
Bastion Asset Management Inc. Invests $2.38 Million in Pfizer Inc. $PFE - MarketBeat
Fifth Third Bancorp Sells 93,615 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) Opinions on Market Rotation to Defensives - Quiver Quantitative
Pfizer Inc. $PFE Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
TCTC Holdings LLC Reduces Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Bought by Aberdeen Group plc - MarketBeat
Public Sector Pension Investment Board Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE - MarketBeat
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings - Insider Monkey
Pfizer Advances VESPER-5 Obesity and Diabetes Trial, Targeting a Key Growth Market - TipRanks
Fund Update: 753,189 PFIZER (PFE) shares added to THORNBURG INVESTMENT MANAGEMENT INC portfolio - Quiver Quantitative
Pfizer Obesity And Hemophilia Advances Spark Fresh Interest In Valuation - Yahoo Finance
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? - Insider Monkey
Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate - simplywall.st
Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - Yahoo Finance
Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America - MarketBeat
Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc - MarketBeat
Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - MarketBeat
Pfizer Inc. $PFE Stake Reduced by GFS Advisors LLC - MarketBeat
Illinois Municipal Retirement Fund Cuts Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer (PFE) Sees Mixed Options Sentiment Amid Stock Downgrade - GuruFocus
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
Varma Mutual Pension Insurance Co Purchases 82,500 Shares of Pfizer Inc. $PFE - MarketBeat
ING Groep NV Lowers Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by LSV Asset Management - MarketBeat
Pfizer (NYSE:PFE) Cut to Neutral at Daiwa Securities Group - MarketBeat
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More - 24/7 Wall St.
Madison Asset Management LLC Has $6.17 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Shares Hit Annual Peak on Regulatory and Strategic Momentum - AD HOC NEWS
Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… - marketscreener.com
Caprock Group LLC Makes New Investment in Pfizer Inc. $PFE - MarketBeat
Daiwa Securities Downgrades Pfizer to Neutral From Outperform, Price Target is $27 - marketscreener.com
Pfizer Hemophilia And Obesity Updates Reshape Growth And Valuation Outlook - Yahoo Finance
Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute - Law360
Pfizer: A Great Opportunity Post Earnings (NYSE:PFE) - Seeking Alpha
Pfizer, SEC Reach $29M End to Scrap Over Insider Trading Settlement - Law.com
Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships - simplywall.st
Is Now the Best Time to Buy Pfizer Stock? - The Globe and Mail
1.63%
1.71%
大文字化:
|
ボリューム (24 時間):